Rat IgG2b isotype control-InVivo

製品コード:A2116         Batch: A211613

印刷

Rat IgG2b isotype control-InVivo monoclonal antibody (Clone:LTF-2) reacts with keyhole limpet hemocyanin (KLH). Because KLH is not expressed by mammals this antibody is ideal for use as an isotype-matched control for rat IgG2b antibodies in most in vivo and in vitro applications.

製品説明

Formulation PBS Buffer, PH 7.4
Clone LTF-2
Isotype Rat IgG2b, κ
Source CHO
Storage
(From the date of receipt)
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Shipping Shipped under low temperature conditions
Sterility 0.2 μM filtered
Purity 99%
Protein concentration 4.76 mg/ml
Endotoxin Level <1EU/mg

カスタマーフィードバック

A2116-Rat IgG2b isotype control-InVivo.gif

A2116 Rat IgG2b isotype control-InVivo-1.gif

A2116 Rat IgG2b isotype control-InVivo-2.gif

A2116 Rat IgG2b isotype control-InVivo-3.gif

Selleckの高級品が、幾つかの出版された研究調査結果(以下を含む)で使われた:

Targeting site-specific N-glycosylated B7H3 induces potent antitumor immunity [ Nat Commun, 2025, 16(1):3546] PubMed: 40229277
Simvastatin overcomes the pPCK1-pLDHA-SPRINGlac axis-mediated ferroptosis and chemo-immunotherapy resistance in AKT-hyperactivated intrahepatic cholangiocarcinoma [ Cancer Commun (Lond), 2025, 10.1002/cac2.70036] PubMed: 40443016
BET inhibitor in combination with BCG vaccine enhances antitumor efficacy and orchestrates T cell reprogramming for melanoma [ Cell Rep Med, 2025, 6(3):101995] PubMed: 40107246
USP19 deficiency enhances T-cell-mediated antitumor immunity by promoting PD-L1 degradation in colorectal cancer [ Pharmacol Res, 2025, S1043-6618(25)00093-3] PubMed: 40020887
Faecalibacterium prausnitzii promotes anti-PD-L1 efficacy in natural killer/T-cell lymphoma by enhancing antitumor immunity [ BMC Med, 2025, 23(1):387] PubMed: 40597177
Myeloid-lineage-specific membrane protein LRRC25 suppresses immunity in solid tumor and is a potential cancer immunotherapy checkpoint target [ Cell Rep, 2025, 44(5):115631] PubMed: 40279244
Tumor microenvironment-associated oxidative stress impairs SIRT1 secretion to suppress anti-tumor immune response [ Cell Rep, 2025, 44(5):115679] PubMed: 40343797
Impact of gut microbiome on radiotherapy and immunotherapy efficacy in microsatellite-stable colorectal cancer: role of propionic acid and B. fragilis [ Br J Cancer, 2025, 10.1038/s41416-025-03105-2] PubMed: 40715695
Lipin1-dependent transcriptional inactivation of SREBPs contributes to selinexor sensitivity in multiple myeloma [ Acta Pharmacol Sin, 2025, 10.1038/s41401-025-01553-3] PubMed: 40229499
Urokinase-type plasminogen activator deficiency enhances CD8+ T cell infiltration and anti-PD-1 therapy efficacy in prostate cancer [ Front Immunol, 2025, 16:1625226] PubMed: 40959092

人間や獣医の診断であるか治療的な使用のためにでない。